Patent applications and USPTO patent grants for Stevens; Howard.The latest application filed is for "immediate/delayed drug delivery".
Patent | Date |
---|---|
Immediate/delayed drug delivery Grant 11,065,205 - Mullen , et al. July 20, 2 | 2021-07-20 |
Immediate/delayed Drug Delivery App 20190125679 - MULLEN; Alexander ;   et al. | 2019-05-02 |
Immediate/delayed drug delivery Grant 10,137,091 - Mullen , et al. November 27, 2 | 2018-11-27 |
Pulsatile drug release Grant 9,474,719 - Mullen , et al. October 25, 2 | 2016-10-25 |
Delayed prolonged drug delivery Grant 9,283,192 - Mullen , et al. March 15, 2 | 2016-03-15 |
Delayed Prolonged Drug Delivery App 20130022677 - Mullen; Alexander ;   et al. | 2013-01-24 |
Pulsatile Drug Release App 20130022676 - Mullen; Alexander ;   et al. | 2013-01-24 |
Immediate/delayed Drug Delivery App 20130017262 - Mullen; Alexander ;   et al. | 2013-01-17 |
Sustained release pharmaceutical composition of diltiazem Grant 5,112,621 - Stevens , et al. May 12, 1 | 1992-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.